Kwang Dong Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Kwang Dong Pharmaceutical is a dividend paying company with a current yield of 1.75% that is well covered by earnings.
Key information
1.8%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 1.8% |
| Future Dividend Yield | n/a |
| Dividend Growth | 8.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩100.000 |
| Payout ratio | 12% |
Recent dividend and buyback updates
Recent updates
Kwang Dong Pharmaceutical's (KRX:009290) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 24
There Is A Reason Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Undemanding
Aug 06Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals
Mar 25Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Right But Growth Is Lacking
Mar 20Is Kwang Dong Pharmaceutical (KRX:009290) Using Too Much Debt?
Apr 29Is Now The Time To Put Kwang Dong Pharmaceutical (KRX:009290) On Your Watchlist?
Apr 06Did Business Growth Power Kwang Dong Pharmaceutical's (KRX:009290) Share Price Gain of 117%?
Mar 18Is Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Popular Amongst Insiders?
Mar 01Should Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Be Part Of Your Dividend Portfolio?
Feb 14Estimating The Fair Value Of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
Feb 01Kwang Dong Pharmaceutical (KRX:009290) Seems To Use Debt Quite Sensibly
Jan 19If You Like EPS Growth Then Check Out Kwang Dong Pharmaceutical (KRX:009290) Before It's Too Late
Jan 06Here's What We Like About Kwang Dong Pharmaceutical's (KRX:009290) Upcoming Dividend
Dec 24
Can You Imagine How Kwang Dong Pharmaceutical's (KRX:009290) Shareholders Feel About The 54% Share Price Increase?
Dec 18Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?
Dec 04What Type Of Shareholders Own The Most Number of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Shares?
Nov 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A009290 has been paying a dividend for less than 10 years.
Growing Dividend: A009290's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Kwang Dong Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A009290) | 1.8% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A009290) (up to 3 years) | n/a |
Notable Dividend: A009290's dividend (1.75%) is higher than the bottom 25% of dividend payers in the KR market (1.24%).
High Dividend: A009290's dividend (1.75%) is low compared to the top 25% of dividend payers in the KR market (4.01%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (11.8%), A009290's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A009290 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kwang Dong Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tae Gi Ha | SK Securities Co., Ltd. |
| Jayaprabha Dhavale | Virtua Research Inc. |